Study type: In vivo/preclinical · Status: Verified against declared source

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons.

Scientific reports · 2022

Study scale: Standard procedures were used for virus injections.

Product or molecular entity relationships

VIP: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

All procedures were carried out in accordance with the European Communities Council Directive of 22 September 2010 on the protection of animals used for scientific purposes (2010/63/EEC) and were approved by the Animal Care and Use Committee of the State Food and Veterinary Service of Lithuania (No.

Methods

Recombinant adeno—associated viruses (rAAV) are extensively used in both research and clinical applications.

Scale or participants

Standard procedures were used for virus injections.

Key findings

Recombinant adeno—associated viruses (rAAV) are extensively used in both research and clinical applications.

Limitations and uncertainty

Recombinant adeno—associated viruses (rAAV) are extensively used in both research and clinical applications.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.